Related Experiment Video

Updated: May 7, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin

Ina Groenkjaer Laugesen, Eva Hauge, Stine Maria Andersen

    Journal of Drugs in Dermatology : JDD
    |October 3, 2013
    PubMed
    Abstract

    Insights

    Valrubicin activates protein kinase C alpha (PKCα), a key enzyme in skin cell regulation. This activation may explain its therapeutic effects on psoriasis and non-melanoma skin cancer.

    Area of Science:

    • Dermatology
    • Molecular Biology
    • Biochemistry

    Background:

    • Valrubicin, an anthracycline, shows promise for treating psoriasis and non-melanoma skin cancer (NMSC) topically.
    • Its mechanism of action remains unclear, though it affects cell proliferation and apoptosis.
    • Valrubicin's structure suggests a link to protein kinase C alpha (PKCα), an enzyme involved in skin cell differentiation.

    Purpose of the Study:

    • To investigate valrubicin's mode of action in keratinocytes.
    • To determine if valrubicin activates PKCα.

    Main Methods:

    • Assessed PKCα translocation from cytoplasm to cell membrane in valrubicin-treated keratinocytes.
    • Measured phosphorylation of downstream targets MARCKS and ERK 1/2.
    • Utilized an in vitro activity assay with purified PKCα.

    Main Results:

    • Valrubicin demonstrated PKCα activation in vitro.
    • Observed PKCα translocation and phosphorylation of downstream signaling molecules.

    Conclusions:

    • Valrubicin stimulates PKCα activity and downstream signaling pathways.
    • This activation may underlie valrubicin's therapeutic benefits in psoriasis and NMSC.

    Related Concept Videos

    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    Skin Cancer01:30

    Skin Cancer

    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    Drugs that Destabilize Microtubules01:10

    Drugs that Destabilize Microtubules

    Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...